Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
about
Probiotics for vulvovaginal candidiasis in non-pregnant womenRole of Probiotics in health improvement, infection control and disease treatment and managementLactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2.The changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health.Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infectionScientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges.Changes in vaginal microbiota following antimicrobial and probiotic therapyRapidly progressive kidney failure induced by fungal mycelia obstructing indwelling ureteral stents.Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicansProbiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicansComparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitisContribution of sortase SrtA2 to Lactobacillus casei BL23 inhibition of Staphylococcus aureus internalization into bovine mammary epithelial cellsComparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal CandidiasisColonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.Vaginal lactobacilli as potential probiotics against Candida SPP.Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women.Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions.Potential role of probiotic bacteria in the treatment and prevention of localised candidosis.Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 Months.Interplay between Lactobacillus rhamnosus GG and Candida and the involvement of exopolysaccharides.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.Probiotics as Antifungals in Mucosal Candidiasis.Future therapies targeted towards eliminating Candida biofilms and associated infections.Oral fungi in HIV: challenges in antifungal therapies.The development of probiotics for women's health.[Microbiota and probiotics: effects on human health].Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study.Local Probiotic Therapy for Vaginal Candida albicans Infections.Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion.Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis.Interstitial cystitis patients' use and rating of complementary and alternative medicine therapies.Probiotics for vulvovaginal candidiasis in non-pregnant women.Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans.
P2860
Q24198021-F1891292-B065-4910-8563-78FFA492797CQ27008261-2FA8D12C-82AF-474E-90BE-D6E49A805832Q34172623-0CE42BEF-07C6-4B4C-8E8B-AD5172AD2BBCQ34268562-21878F2A-D5A8-4078-B495-5372E512C0DCQ34602921-C9045225-793D-42AC-8B3E-87FD1026E4A1Q35681666-A7521D1C-1016-462D-BCC7-568F513B98CDQ35800667-33861317-1E58-429F-AACA-0E5FA2D5E11FQ35963849-343C319A-8116-4AA5-92C9-68BE3697AA6DQ35978379-6B7670C9-778A-4325-A8FC-D9699B0C426CQ36090736-55114638-3ADF-48F0-965B-B4ECE91075B7Q36116305-EB5D924D-2970-4846-BA87-8B3F3559745EQ36186078-B1F7B52C-52DA-419D-8D29-1AEDDA2FEF24Q36316476-6BF242C9-B49F-45EB-9EF2-537B672B2F0CQ36355379-06050210-58D9-4341-9EB4-8BFA4638482EQ36509561-D0E7FE3E-F588-4E78-B70C-5710CB6EB2EEQ36516482-C26A65C9-BA5A-4AD2-B925-ABD6F082A4E0Q37159489-5735440C-9F4F-4D43-A761-1F6218ADC218Q37280955-1FA9DE8D-F841-4403-A37D-1FABA96CCE8EQ37520271-43038A4E-3886-4A87-9779-EA46B798C7DEQ37736301-FEB3D84D-ED65-4A38-9455-10DD684D711CQ37889385-00D1F551-EFB3-412F-9ED0-8F48404C31B8Q38292416-C475ACD1-7C57-42A7-92FF-BF237BFCD913Q38644001-7496A2E0-A42A-4B36-A9B0-093E13290143Q38696236-948B6495-AF47-4C80-B1E9-E8CAE53CBAA5Q38702214-3C6D5A2B-FFD8-4145-A1B9-BA6B8CB08F76Q38716578-68D91F43-34AE-42F9-8571-5CFA75C6BBE0Q38786061-15677676-4B95-4901-A788-508F6A7591CAQ38816198-5826B2C0-23DA-44E2-985D-F0C614264DA3Q38972102-B6299389-A2DF-4427-B5EA-DC4E099136EBQ39281119-E13D2C4E-A25A-4067-90BA-2A679AC10357Q40458954-8B4EAD77-777B-4AF3-BABB-BD31C77EF930Q41681212-ABEF8796-2271-4700-982C-639AF01EE4CEQ42375693-533541CE-041A-4473-AAD0-69852828D96AQ43661996-E7BABEE0-DFBE-414A-86C0-3CBC6C0E67FAQ46057716-1DECC63E-A2EB-4E1C-85ED-D1F42B7C3D0EQ46255477-96E523BD-0EC9-46F8-8CCC-EB310FF032ECQ48280257-511D4499-7305-4DA9-B44B-86633F87E770
P2860
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@en
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@nl
type
label
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@en
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@nl
prefLabel
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@en
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@nl
P2093
P2860
P1476
Improved treatment of vulvovag ...... d Lactobacillus reuteri RC-14.
@en
P2093
E C P De Martinis
J C Ferreira
R C Candido
R C R Martinez
S A Franceschini
S M Quintana
P2860
P304
P356
10.1111/J.1472-765X.2008.02477.X
P577
2009-02-02T00:00:00Z